Arrowhead Pharmaceuticals (ARWR) Q2 2020 Earnings

7MayConfirmed
Q3 2019
Q4 2019
Q1 2020
Q2 2020
-0.2
-0.01
0.18
0.37

Details

Expected EPS
-0.1
Actual EPS
-0.2
Surprise EPS
-0.1
Surprise Percent
+100%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -0.2 per share for Q2 2020.

0 Comments

Share your thoughts